Compugen Ltd., a clinical-stage cancer immunotherapy company, announced its management will participate in a fireside chat and hold meetings at the H.C. Wainwright 28th Annual Global Investment Conference in New York City on September 14-16, 2026. The fireside chat is scheduled for September 14 at 3:30 PM ET and will be webcast live on Compugen's website, with a replay available afterward. Compugen specializes in AI-powered drug target discovery and is developing several cancer immunotherapy candidates, including COM701, rilvegostomig, and GS-0321, some in collaboration with AstraZeneca and Gilead. This event provides investors a chance to hear directly from management about their innovative pipeline and clinical progress.
Oracle's stock has dropped significantly, trading at $158.78 against a Wall Street consensus target of $242.05, due to massive capital expenditures and negative free cash flow. Despite this, analysts remain bullish, citing Oracle's rapid cloud infras...
Qualcomm is pursuing an aggressive product strategy including Connectivity, AI Accelerators, Custom ASICs, and Arm-Based Server CPUs to gain market share through fiscal year 2029. Strategic acquisitions like Nuvia, Alphawave, and Modular, along with ...
Bloom Energy Corporation reported a record Q2 2026 with over $1 billion in revenue, marking 165.5% year-over-year growth and a 34.3% non-GAAP gross margin. The company benefits from rising AI-driven data center power needs, offering fast, scalable, a...
NVIDIA reported record-breaking Q2 results driven by strong AI demand and data center growth, reinforcing its status as a long-term buy. Management forecasts 70% revenue growth next fiscal year, supported by expanding AI infrastructure and new produc...
V2X, Inc. secured a $19 million contract from the U.S. Marine Corps to deliver Tempest counter-Unmanned Aerial System vehicles. These mobile systems are designed to detect and neutralize drone threats, enhancing battlefield protection for maneuver fo...
